Circulating miR-30b and miR-30c predict erlotinib response in EGFR-mutated non-small cell lung cancer patients

Lung Cancer ◽

10.1016/j.lungcan.2019.07.005 ◽

2019 ◽

Vol 135 ◽

pp. 92-96 ◽

Cited By ~ 5

Author(s):

Johanne Andersen Hojbjerg ◽

Eva Boysen Fynboe Ebert ◽

Michelle Simone Clement ◽

Anne Winther-Larsen ◽

Peter Meldgaard ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Cell Lung Cancer ◽

Small Cell ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Egfr Mutated

Download Full-text

Faculty Opinions recommendation of Randomized Adjuvant Chemotherapy of EGFR-Mutated Non-Small Cell Lung Cancer Patients with or without Icotinib Consolidation Therapy.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.725853745.793510697 ◽

2015 ◽

Author(s):

Alexandru Grigorescu

Keyword(s):

Lung Cancer ◽

Adjuvant Chemotherapy ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Cell Lung Cancer ◽

Small Cell ◽

Consolidation Therapy ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Egfr Mutated

Download Full-text

Utility of T790M plasma and tissue biopsy testing in EGFR mutated non-small-cell lung cancer patients

Lung Cancer ◽

10.1016/s0169-5002(20)30167-7 ◽

2020 ◽

Vol 139 ◽

pp. S61-S62

Author(s):

E. Preda ◽

J. Shamash ◽

K. Tarver ◽

S. Ball

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Cell Lung Cancer ◽

Small Cell ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Tissue Biopsy ◽

Egfr Mutated

Download Full-text

Plasmatic Tumor Dna Assessments Predict Clinical Outcome in Egfr-Mutated Non-Small Cell Lung Cancer Patients Treated By Egfr Inhibitors

Annals of Oncology ◽

10.1093/annonc/mdu349.59 ◽

2014 ◽

Vol 25 ◽

pp. iv450

Author(s):

N. Pecuchet ◽

A. Didelot ◽

E. Zonta ◽

C. Lours ◽

L. Gibault ◽

...

Keyword(s):

Lung Cancer ◽

Clinical Outcome ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Cell Lung Cancer ◽

Small Cell ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Egfr Mutated ◽

Tumor Dna

Download Full-text

P2.03-035 Osimertinib in Relapsed EGFR-Mutated Non-Small Cell Lung Cancer Patients with Brain Metastases: Results from the TREM-Study

Journal of Thoracic Oncology ◽

10.1016/j.jtho.2017.09.1286 ◽

2017 ◽

Vol 12 (11) ◽

pp. S2140-S2141

Author(s):

I.J. Eide ◽

Å. Helland ◽

S. Borrisova ◽

S. Ekman ◽

S. Cicenas ◽

...

Keyword(s):

Lung Cancer ◽

Brain Metastases ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Cell Lung Cancer ◽

Small Cell ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Egfr Mutated

Download Full-text

Randomized Adjuvant Chemotherapy of EGFR-Mutated Non-Small Cell Lung Cancer Patients with or without Icotinib Consolidation Therapy

PLoS ONE ◽

10.1371/journal.pone.0140794 ◽

2015 ◽

Vol 10 (10) ◽

pp. e0140794 ◽

Cited By ~ 9

Author(s):

Siyang Feng ◽

Yuanyuan Wang ◽

Kaican Cai ◽

Hua Wu ◽

Gang Xiong ◽

...

Keyword(s):

Lung Cancer ◽

Adjuvant Chemotherapy ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Cell Lung Cancer ◽

Small Cell ◽

Consolidation Therapy ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Egfr Mutated

Download Full-text

Pharmacokinetics of edoxaban in EGFR-mutated non-small cell lung cancer patients with venous thromboembolism

Respiratory Investigation ◽

10.1016/j.resinv.2020.11.007 ◽

2020 ◽

Author(s):

Takamasa Hotta ◽

Yukari Tsubata ◽

Kosuke Hamai ◽

Akari Tanino ◽

Misato Kobayashi ◽

...

Keyword(s):

Lung Cancer ◽

Venous Thromboembolism ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Cell Lung Cancer ◽

Small Cell ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Egfr Mutated

Download Full-text

Intracranial effect of osimertinib in relapsed EGFR-mutated T790M-positive and -negative non-small cell lung cancer patients: results from a phase II study

Acta Oncologica ◽

10.1080/0284186x.2021.1973092 ◽

2021 ◽

pp. 1-7

Author(s):

Inger Johanne Zwicky Eide ◽

Harald Grut ◽

Åslaug Helland ◽

Simon Ekman ◽

Jens Benn Sørensen ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Small Cell ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Egfr Mutated

Download Full-text

EGFR mutated non-small cell lung cancer patients: More prone to development of bone and brain metastases?

Lung Cancer ◽

10.1016/j.lungcan.2014.01.006 ◽

2014 ◽

Vol 84 (1) ◽

pp. 86-91 ◽

Cited By ~ 57

Author(s):

L.E.L. Hendriks ◽

E.F. Smit ◽

B.A.H. Vosse ◽

W.W. Mellema ◽

D.A.M. Heideman ◽

...

Keyword(s):

Lung Cancer ◽

Brain Metastases ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Cell Lung Cancer ◽

Small Cell ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Egfr Mutated

Download Full-text

EGFR mutation tracking predicts survival in advanced EGFR-mutated non-small cell lung cancer patients treated with osimertinib

Translational Lung Cancer Research ◽

10.21037/tlcr.2020.03.02 ◽

2020 ◽

Vol 9 (2) ◽

pp. 239-245 ◽

Cited By ~ 1

Author(s):

Anna Buder ◽

Maximilian J. Hochmair ◽

Ulrike Setinek ◽

Robert Pirker ◽

Martin Filipits

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Cell Lung Cancer ◽

Egfr Mutation ◽

Small Cell ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Egfr Mutated

Download Full-text

Phase 1b study of ramucirumab in combination with erlotinib or osimertinib for untreated EGFR-mutated non–small cell lung cancer patients with asymptomatic brain metastases

Investigational New Drugs ◽

10.1007/s10637-021-01147-w ◽

2021 ◽

Author(s):

Hiroyasu Kaneda ◽

Kenji Sawa ◽

Haruko Daga ◽

Asuka Okada ◽

Yuki Nakatani ◽

...

Keyword(s):

Lung Cancer ◽

Brain Metastases ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Cell Lung Cancer ◽

Small Cell ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Phase 1B ◽

Egfr Mutated

Download Full-text